SCHEMBL23083642

SCHEMBL23083642

CCCCC(CC)COC(=O)CCSc1ccn2ccnc2c1Cl

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.46
▸ TSHR P16473 3/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46
▸ ATM Q13315 1/20 0.46
▸ ALDH1A1 P00352 5/20 0.43
▸ MAPK1 P28482 3/20 0.43
▸ CA2 P00918 1/20 0.39
▸ PRSS1 P07477 1/20 0.38
▸ PRSS2 P07478 1/20 0.38
▸ PRSS3 P35030 1/20 0.38
▸ LMNA P02545 3/20 0.37
▸ HSD17B10 Q99714 1/20 0.36
▸ RECQL P46063 1/20 0.36
▸ THRB P10828 2/20 0.32
▸ PDE1A P54750 2/20 0.32
▸ PDE1B Q01064 2/20 0.32
▸ PDE1C Q14123 2/20 0.32
▸ TNF P01375 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25398148 0.85 CYP3A4 (0.44) CYP3A4TSHRTDP1ATMALDH1A1
SCHEMBL25394269 0.84 CYP3A4 (0.43) CYP3A4TSHRTDP1ATMALDH1A1
SCHEMBL19785248 0.83 CYP3A4 (0.50) CYP3A4TSHRTDP1ATMALDH1A1
SCHEMBL21383708 0.82 CYP3A4 (0.49) CYP3A4TSHRTDP1ATMALDH1A1
SCHEMBL31057983 0.82 CYP3A4 (0.49) CYP3A4TSHRTDP1ATMALDH1A1
SCHEMBL21154729 0.82 CYP3A4 (0.46) CYP3A4TSHRTDP1ATMALDH1A1
SCHEMBL19785519 0.82 CYP3A4 (0.48) CYP3A4TSHRTDP1ATMALDH1A1
SCHEMBL29679787 0.82 CYP3A4 (0.48) CYP3A4TSHRTDP1ATMALDH1A1
SCHEMBL19785269 0.82 CYP3A4 (0.48) CYP3A4TSHRTDP1ATMALDH1A1
SCHEMBL21856067 0.81 CYP3A4 (0.47) CYP3A4TSHRTDP1ATMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021043077-A1 SUBSTITUTED PYRAZINE COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2021-03-11 — — WO disclosed
Send feedback